Atlas Trials

Merus B.V.

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Merus B.V.

RecordFirmDate
Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer (NCT07353957)Merus B.V.2026-03-27
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1) (NCT06525220)Merus B.V.2024-09-25
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2) (NCT06496178)Merus B.V.2024-06-25
Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination (NCT04868877)Merus B.V.2021-04-28
A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies (NCT03922204)Merus B.V.2019-05-08
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors (NCT03526835)Merus B.V.2018-05-02
MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer. (NCT03321981)Merus B.V.2018-01-15

Track Merus B.V. automatically

Every clearance here is in the API, with alerts when new ones post.